Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus-19 – The IONIC Trial Protocol
Kavi Sharma, Lisa Berry, Evangelos Vryonis, Asad Ali, Beatriz Lara, Angela Noufaily, Nick Parsons, Christopher James Bradley, Becky Haley, Tabuso Maria, Ramesh Arasaradnam
doi: https://doi.org/10.1101/2021.07.13.21258757
Kavi Sharma
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Lisa Berry
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Evangelos Vryonis
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Asad Ali
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Beatriz Lara
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Angela Noufaily
2Warwick Medical School, Coventry, CV4 7AL
Nick Parsons
2Warwick Medical School, Coventry, CV4 7AL
Christopher James Bradley
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Becky Haley
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Tabuso Maria
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Ramesh Arasaradnam
1University Hospitals Coventry & Warwickshire, Coventry, CV22DX
Data Availability
Data from this study will be made available to researchers who provide a methodologically sound proposal in writing to the Sponsor, following the publication of the main study paper. Anonymised, individual participant data, data dictionary, study protocol and statistical analysis plan will be accessible upon application.
Posted July 15, 2021.
Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus-19 – The IONIC Trial Protocol
Kavi Sharma, Lisa Berry, Evangelos Vryonis, Asad Ali, Beatriz Lara, Angela Noufaily, Nick Parsons, Christopher James Bradley, Becky Haley, Tabuso Maria, Ramesh Arasaradnam
medRxiv 2021.07.13.21258757; doi: https://doi.org/10.1101/2021.07.13.21258757
Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus-19 – The IONIC Trial Protocol
Kavi Sharma, Lisa Berry, Evangelos Vryonis, Asad Ali, Beatriz Lara, Angela Noufaily, Nick Parsons, Christopher James Bradley, Becky Haley, Tabuso Maria, Ramesh Arasaradnam
medRxiv 2021.07.13.21258757; doi: https://doi.org/10.1101/2021.07.13.21258757
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (623)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11694)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3679)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2361)
- Health Policy (925)
- Hematology (339)
- HIV/AIDS (772)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3436)
- Nursing (194)
- Nutrition (519)
- Oncology (1800)
- Ophthalmology (533)
- Orthopedics (216)
- Otolaryngology (285)
- Pain Medicine (230)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6083)
- Radiology and Imaging (1254)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)